IDERA PHARMACEUTICALS, INC. 4
4 · IDERA PHARMACEUTICALS, INC. · Filed May 20, 2008
Insider Transaction Report
Form 4
WYNGAARDEN JAMES B
Director
Transactions
- Exercise/Conversion
Common Stock
2008-05-16$4.00/sh+1,000$4,000→ 37,685 total - Sale
Common Stock
2008-05-16$14.79/sh−1,000$14,790→ 36,685 total - Exercise/Conversion
Common Stock
2008-05-16$4.00/sh+4,990$19,960→ 41,675 total - Exercise/Conversion
Stock Options
2008-05-16−1,000→ 0 totalExercise: $4.00From: 2000-06-08Exp: 2009-06-08→ Common Stock (1,000 underlying) - Sale
Common Stock
2008-05-16$14.79/sh−4,990$73,802→ 36,685 total - Exercise/Conversion
Stock Options
2008-05-16−4,990→ 0 totalExercise: $4.00From: 2001-03-01Exp: 2009-05-17→ Common Stock (4,990 underlying)